China Medical System Holdings LtdChina Medical System Holdings Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

The report of China Medical System Holdings Ltd leverages information from across the internet as well as from public filings by China Medical System Holdings Ltd. The SDG score for China Medical System Holdings Ltd represents its transparency towards the UN SDGs. The report of China Medical System Holdings Ltd was prepared by All Street Sevva using advanced Cognitive Robots.

China Medical System Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 5.7, social score of 5.0 and governance score of 7.0.

SDG Transparency Score for China Medical System Holdings Ltd 
Low
0 - 3

5.9

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for China Medical System Holdings Ltd 
5.7

Environmental

5.0

Social

7.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
669Viridian Therapeutics Inc
6.0
High
669Vistin Pharma ASA
6.0
High
716China Medical System Holdings Ltd
5.9
High
716Akeso Inc
5.9
High
716Alfresa Holdings Corp
5.9
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does China Medical System Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd offer flexible work?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does China Medical System Holdings Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose water use targets?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did China Medical System Holdings Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has China Medical System Holdings Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is China Medical System Holdings Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose its waste policy?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose energy use targets?

LockedSign up for free to unlock

Does China Medical System Holdings Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does China Medical System Holdings Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for China Medical System Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.

Sorry!

Failed to process!